 Boston-based Valo Health LLC has agreed to go public through a reverse merger with a blank-check firm backed by venture capitalist Vinod Khosla, in a deal valuing the combined company at about 2.8 billion. Founded in 2019, Valo Health is a biotech company that uses data analysis and artificial intelligence to help drug discovery and development. 